Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Calandra

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|February 10, 2017
Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early LifeThierry Roger, Luregn J Schlapbach, Anina Schneider, et al.
The Journal of Experimental Medicine|May 29, 2013
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionStéphanie Bibert, Thierry Roger, Thierry Calandra, et al.
Open Forum Infectious Diseases|March 21, 2020
Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal CandidiasisFrederic Lamoth, Cornelius J Clancy, Frederic Tissot, et al.
Critical Care (London, England)|May 18, 2016
Advances in antibiotic therapy in the critically illJean-Louis Vincent, Matteo Bassetti, Bruno François, et al.
The Journal of Biological Chemistry|June 3, 2010
Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of actionHajer Ouertatani-Sakouhi, Farah El-Turk, Bruno Fauvet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsisMarieke Emonts, Fred C G J Sweep, Nicolai Grebenchtchikov, et al.
Blood|October 20, 2010
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infectionThierry Roger, Jérôme Lugrin, Didier Le Roy, et al.
European Journal of Immunology|February 26, 2013
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active diseaseMatthieu Perreau, Virginie Rozot, Hugh C Welles, et al.
The Journal of Endocrinology|June 23, 2010
Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in miceVéronique Serre-Beinier, Christian Toso, Philippe Morel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancerWalter T Hughes, Donald Armstrong, Gerald P Bodey, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|February 10, 2017
Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early LifeThierry Roger, Luregn J Schlapbach, Anina Schneider, et al.
The Journal of Experimental Medicine|May 29, 2013
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionStéphanie Bibert, Thierry Roger, Thierry Calandra, et al.
Open Forum Infectious Diseases|March 21, 2020
Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal CandidiasisFrederic Lamoth, Cornelius J Clancy, Frederic Tissot, et al.
Critical Care (London, England)|May 18, 2016
Advances in antibiotic therapy in the critically illJean-Louis Vincent, Matteo Bassetti, Bruno François, et al.
The Journal of Biological Chemistry|June 3, 2010
Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of actionHajer Ouertatani-Sakouhi, Farah El-Turk, Bruno Fauvet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsisMarieke Emonts, Fred C G J Sweep, Nicolai Grebenchtchikov, et al.
Blood|October 20, 2010
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infectionThierry Roger, Jérôme Lugrin, Didier Le Roy, et al.
European Journal of Immunology|February 26, 2013
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active diseaseMatthieu Perreau, Virginie Rozot, Hugh C Welles, et al.
The Journal of Endocrinology|June 23, 2010
Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in miceVéronique Serre-Beinier, Christian Toso, Philippe Morel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2002
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancerWalter T Hughes, Donald Armstrong, Gerald P Bodey, et al.
Pageof 19